Shun Nishino1, Nozomi Watanabe2, Toshiyuki Kimura2, Maurice Enriquez-Sarano2, Tatsuya Nakama2, Makoto Furugen2, Hiroshi Koiwaya2, Keiichi Ashikaga2, Nehiro Kuriyama2, Yoshisato Shibata2. 1. From the Department of Cardiology, Miyazaki Medical Association Hospital Cardiovascular Center, Japan (S.N., N.W., T.N., M.F., H.K., K.A., N.K., Y.S.); and Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (T.K., M.E.-S.). n_watanabe@cure.or.jp. 2. From the Department of Cardiology, Miyazaki Medical Association Hospital Cardiovascular Center, Japan (S.N., N.W., T.N., M.F., H.K., K.A., N.K., Y.S.); and Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (T.K., M.E.-S.).
Abstract
BACKGROUND: Previously published evidence on ischemic mitral regurgitation (IMR) and its adverse prognosis after myocardial infarction has been based on the severity of IMR in the subacute or chronic period of myocardial infarction. However, the state of IMR can vary from the early stage to the chronic stage as a result of various responses of myocardium after primary percutaneous coronary intervention (PCI). METHODS AND RESULTS: Standard echocardiography was serially performed in 546 consecutive patients with first-onset acute myocardial infarction (1) immediately after their arrival (pre-PCI), (2) before discharge (early post-PCI), and (3) 6 to 8 months after PCI (late post-PCI). The course of IMR after primary PCI and the prognostic impact of the IMR in each phase were investigated. IMR was found in 193/546 (35%) patients at the emergency room. In the acute phase after PCI, IMR improved in 63 patients. IMR worsened in 78 patients despite successful PCI. Shorter onset-to-reperfusion time and nontotal occlusion before PCI were the independent predictors of early improvement of IMR. In the chronic phase, IMR improved in 79 patients and worsened in 36 patients. Lower peak creatine kinase-myocardial band was an independent predictor of late improvement of IMR. IMR before PCI worsened 30-day prognosis (P=0.02), and persistent IMR in the chronic phase worsened long-term prognosis (P=0.04) after primary PCI. CONCLUSIONS: Degrees of IMR changed in the early and chronic phase after primary PCI for acute myocardial infarction. IMR on arrival and persistent IMR in the chronic phase worsened short-term and long-term prognosis after acute myocardial infarction, respectively.
BACKGROUND: Previously published evidence on ischemic mitral regurgitation (IMR) and its adverse prognosis after myocardial infarction has been based on the severity of IMR in the subacute or chronic period of myocardial infarction. However, the state of IMR can vary from the early stage to the chronic stage as a result of various responses of myocardium after primary percutaneous coronary intervention (PCI). METHODS AND RESULTS: Standard echocardiography was serially performed in 546 consecutive patients with first-onset acute myocardial infarction (1) immediately after their arrival (pre-PCI), (2) before discharge (early post-PCI), and (3) 6 to 8 months after PCI (late post-PCI). The course of IMR after primary PCI and the prognostic impact of the IMR in each phase were investigated. IMR was found in 193/546 (35%) patients at the emergency room. In the acute phase after PCI, IMR improved in 63 patients. IMR worsened in 78 patients despite successful PCI. Shorter onset-to-reperfusion time and nontotal occlusion before PCI were the independent predictors of early improvement of IMR. In the chronic phase, IMR improved in 79 patients and worsened in 36 patients. Lower peak creatine kinase-myocardial band was an independent predictor of late improvement of IMR. IMR before PCI worsened 30-day prognosis (P=0.02), and persistent IMR in the chronic phase worsened long-term prognosis (P=0.04) after primary PCI. CONCLUSIONS: Degrees of IMR changed in the early and chronic phase after primary PCI for acute myocardial infarction. IMR on arrival and persistent IMR in the chronic phase worsened short-term and long-term prognosis after acute myocardial infarction, respectively.
Authors: Dae-Hee Kim; Jacob P Dal-Bianco; Elena Aikawa; Joyce Bischoff; Robert A Levine Journal: Circ Cardiovasc Imaging Date: 2018-04 Impact factor: 7.792
Authors: Dan Haberman; Rodrigo Estévez-Loureiro; Tomas Benito-Gonzalez; Paolo Denti; Dabit Arzamendi; Marianna Adamo; Xavier Freixa; Luis Nombela-Franco; Pedro Villablanca; Lian Krivoshei; Neil Fam; Konstantinos Spargias; Andrew Czarnecki; Isaac Pascual; Fabien Praz; Doron Sudarsky; Arthur Kerner; Vlasis Ninios; Marco Gennari; Ronen Beeri; Leor Perl; Haim Danenberg; Lion Poles; Sara Shimoni; Sorel Goland; Berenice Caneiro-Queija; Salvatore Scianna; Igal Moaraf; Davide Schiavi; Claudia Scardino; Noé Corpataux; Julio Echarte-Morales; Michael Chrissoheris; Estefanía Fernández-Peregrina; Mattia Di Pasquale; Ander Regueiro; Carlos Vergara-Uzcategui; Andres Iñiguez-Romo; Felipe Fernández-Vázquez; Danny Dvir; Maurizio Taramasso; Mony Shuvy Journal: J Clin Med Date: 2021-04-22 Impact factor: 4.241
Authors: Pieter van der Bijl; Rachid Abou; Laurien Goedemans; Bernard J Gersh; David R Holmes; Nina Ajmone Marsan; Victoria Delgado; Jeroen J Bax Journal: ESC Heart Fail Date: 2020-02-14
Authors: Leor Perl; Tamir Bental; Katia Orvin; Hana Vaknin-Assa; Gabriel Greenberg; Pablo Codner; Yaron Shapira; Mordehay Vaturi; Alexander Sagie; Ran Kornowski Journal: Front Cardiovasc Med Date: 2022-01-13
Authors: Harish Sharma; Mengshi Yuan; Iqra Shakeel; James Hodson; Ashwin Radhakrishnan; Samuel Brown; John May; Kieran O'Connor; Nawal Zia; Sagar N Doshi; Sandeep S Hothi; Jonathan N Townend; Saul G Myerson; Peter F Ludman; Richard P Steeds; M Adnan Nadir Journal: J Clin Med Date: 2022-02-13 Impact factor: 4.241